The Netherlands Medicine Assessments Board announced that it will begin investigating the anti-depressant drug nefazodone after receiving reports of serious side effects from its use.
Since it became available in the Netherlands in 1994, the Medicine Assessment Board (CBG), has received 26 reports of serious liver failure and, in some cases, deaths related to the drug worldwide.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!